Methanthelinium Bromide

溴甲胺太林

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameMethanthelinium Bromide
Drug Alias Name溴苯辛bromuro de metanteliniomethanthelinii bromidum溟本辛美生溴铵 +[9
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMuscarinic acetylcholine receptor antagonists
TargetsMuscarinic acetylcholine receptor
Therapy Area/IndicationsUrinary IncontinenceUrinary Bladder, NeurogenicSpasm +[4
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermany
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Active IndicationsUrinary IncontinenceSpasmPeptic Ulcer
Inactive IndicationsUrinary Bladder, Neurogenic

Other Information

ATC CodeA03AB07
Related LinksDrugBankKEGG